Supporting these results, we identified no PDGFRA mutations in any of the tumors, only one MET mutation in the LCNEC group, whereas three KIT mutations were found exclusively in LCNEC cases. This evidence concerns the gene PDGFRA and large cell neuroendocrine carcinoma.